Skeletal Care Academy
What is the Skeletal Care Academy?
The Skeletal Care Academy (SCA) is an education programme developed to ensure that patients with cancer-related bone disease receive the highest standard of multi-professional care, allowing them to enjoy fuller, healthier lives.
The SCA is committed to advancing the understanding of cancer-related bone disease through continuing education. The purpose is to provide a wide variety of high-quality educational programmes and additional resources for physicians, nurses, other healthcare professionals and patients.
What does the Skeletal Care Academy programme involve?
The programme centres on an annual meeting, which provides an accelerated learning programme to equip the participants with the knowledge they need to become experts in cancer-related bone disease. After completing the programme, participants will be able to provide peer-to-peer education within their individual countries.
The programme is open to physicians, nurses and patient advocates and includes joint sessions as well as specialist worsktreams.
2010 meeting: 12-13 March, Paris
The SCA 2010 meeting is a train-the-trainer meeting which will focus on cancer-related bone disease including:
- Bone health in patients with bone loss due to hormone ablation therapy
- Cancer-induced bone disease resulting from metastatic solid tumours
- Diseases known to be associated with a high prevalence of cancer-related bone disease such as multiple myeloma, prostate and breast cancer
Sessions will cover the latest scientific thinking and treatment options for cancer-related bone disease; plenary, workshop sessions, discussions and debates will be included.
Physicians and nurses can earn CME points by attending the SCA meeting.
The Central European Cooperative Oncology Group (CECOG) will host the Skeletal Care Academy 2010 meeting, with support from:
- European School of Oncology (ESO)
- European Oncology Nursing Society (EONS)
- European Association of Urology Nurses (EAUN)
- European Bone Marrow and Transplantation Nursing Group (EBMT-NG)
The SCA is supported by Amgen Oncology.
How is the SCA programme developed?
The SCA is led by a distinguished steering committee of international experts from the field of cancer-related bone disease. Represented on the SCA steering committee are oncologists, urologists, surgeons, nurses and patient advocacy groups. The steering committee provides input on the programme content and the direction of the SCA, as well as professional insight on clinical practice in bone disease.
In addition to the SCA steering committee, there are dedicated nursing and patient advocacy steering committees - each with representation on the SCA steering committee.
How can I apply to participate in the SCA?
This programme is open to healthcare professionals involved in the management of patients with cancer and cancer-related bone disease. Representatives from oncology and associated patient advocacy organisations will also be invited to attend the meeting.
Please complete the online registration form to apply, which can be found at: www.skeletalcareacademy.com. As places are limited, we will contact you to confirm your place on receipt of your registration.
Who should I contact to get further information about the SCA?
Please contact Medical Knowledge Group, the SCA programme coordinator with any questions or to request further information. Additional information can also be found on the SCA website: www.skeletalcareacademy.com.
Skeletal Care Academy
Medical Knowledge Group
20 Soho Square
London
W1D 3QW
Telephone: +44 207 413 3249
Fax: +44 207 413 3110
Email: skeletalcareacademy@medicalknowledgegroup.com
European Oncology Nursing SocietyAvenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu